Merlin Biomed
18
30M
16
0.75
0.11
11
- Stages of investment
- Areas of investment
Summary
Merlin Biomed appeared to be the Corporate Investor, which was created in 1998. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the New York.
Among the most popular fund investment industries, there are Health Care, Biopharma. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight ARIAD Pharmaceuticals, FibroGen, Calypso Medical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The average startup value when the investment from Merlin Biomed is 10-50 millions dollars. Opposing the other organizations, this Merlin Biomed works on 36 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2003. The fund is constantly included in less than 2 deals per year.
The fund was created by Stuart T. Weisbrod.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Merlin Biomed, startups are often financed by Bay City Capital, Versant Ventures, Venrock. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, VantagePoint Capital Partners, OrbiMed. In the next rounds fund is usually obtained by OrbiMed, MPM Capital, Sanderling Ventures.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 0
- Exits
- 11
- Rounds per year
- 0.75
- Follow on index
- 0.11
- Investments by industry
- Biotechnology (12)
- Pharmaceutical (8)
- Health Care (8)
- Therapeutics (6)
- Medical (5) Show 7 more
- Investments by region
-
- United States (14)
- United Kingdom (2)
- Canada (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 111M
- Group Appearance index
- 0.94
- Avg. company exit year
- 14
- Avg. multiplicator
- 2.28
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Confluent Surgical | 25 Jun 2002 | Information Technology, Health Care, Manufacturing | Late Stage Venture | 20M | United States, Massachusetts, Waltham |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.